However, we found that the ability of the ERV-K-Env TCR to recognize and kill HIV-1-infected cells does not translate well to the setting of healthy HIV-1-seronegative donors, suggesting that the ERV-K-Env peptide is not an immunogenic tumor-associated antigen. The gene discussed is ERVW-1; the disease is neoplasm.